SCHEMBL22192541

SCHEMBL22192541

c1ccc(-c2cc(-c3ccccc3)nc(-n3c4c(ccc5c6ccccc6oc54)c4ccc5c6ccccc6n(-c6ccccc6)c5c43)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
ATM Q13315 1/20 0.36
ALDH1A1 P00352 4/20 0.33
PPARG P37231 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
NR2E3 Q9Y5X4 1/20 0.33
NCOR2 Q9Y618 1/20 0.33
KMT2A Q03164 4/20 0.32
MEN1 O00255 3/20 0.32
LMNA P02545 2/20 0.32
POLB P06746 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TSHR P16473 1/20 0.32
BRCA1 P38398 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MAPT P10636 3/20 0.31
CSF1R P07333 1/20 0.31
PDGFRB P09619 1/20 0.31
KIT P10721 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22192502 0.96 KDM4E (0.36) KDM4EL3MBTL1ATMALDH1A1PPARG
SCHEMBL22192337 0.94 KDM4E (0.35) KDM4EL3MBTL1ATMALDH1A1PPARG
SCHEMBL22192267 0.93 KDM4E (0.34) KDM4EL3MBTL1ATMALDH1A1PPARG
SCHEMBL15625540 0.92 MAPT (0.34) KDM4EL3MBTL1ATMALDH1A1KMT2A
SCHEMBL8819282 0.92 KDM4E (0.33) KDM4EL3MBTL1ATMALDH1A1PPARG
SCHEMBL18620572 0.91 KDM4E (0.33) KDM4EL3MBTL1ATMALDH1A1PPARG
SCHEMBL22192501 0.91 KDM4E (0.33) KDM4EL3MBTL1ATMALDH1A1PPARG
SCHEMBL22192319 0.91 KDM4E (0.37) KDM4EL3MBTL1ATMALDH1A1PPARG
SCHEMBL17904155 0.90 KDM4E (0.35) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL15625557 0.90 ALOX5 (0.34) KDM4EL3MBTL1ALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10703762-B2 Compound, material for organic electroluminescence device, organic electroluminescence device and electronic apparatus IDEMITSU KOSAN CO., LTD. (JP) 2020-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10703762-B2 Compound, material for organic electroluminescence device, organic electroluminescence device and electronic apparatus PIEZO1, OR10J3, EPCAM KDM4E 3529/4885L3MBTL1 2738/4885ATM 1283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.